Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pleural Photodynamic Therapy for NSCLC
NCT00601848Phase 2Terminated
- Sponsor
- Abramson Cancer Center
- Start
- Nov 2004
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of porfimer sodium in non-small cell lung cancer (NSCLC), sponsored by Abramson Cancer Center. Started Nov 2004; status: terminated.
02
Drugs
porfimer sodium
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00601848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00601848.